2 Firms Seek To Lead GW Pharma Suit Over $7.2B Deal
By Katryna Perera ( August 4, 2021, 8:11 PM EDT) -- Monteverde & Associates and Kahn Swick & Foti have asked a California federal judge to appoint them co-lead counsel of a proposed securities class action against GW Pharmaceuticals over claims that the cannabinoid-derived treatment manufacturer misled investors to achieve a $7.2 billion acquisition deal with Ireland-based Jazz Pharmaceuticals....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.